About Oxurion NV
Ticker
info
OXUR
Trading on
info
BR
ISIN
info
BE0003846632
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Pascal Ghoson
Headquarters
info
Gaston Geenslaan 1, Leuven, undefined, Belgium, 3001
Employees
info
11
Website
info
oxurion.com
Oxurion NV, a biopharmaceutical company, develops medicines to prevent blindness in Belgium. The company is developing ophthalmic treatments to preserve vision for patients with retinal disorders, including geographic atrophy and age-related macular degeneration. The company was formerly known as ThromboGenics NV and changed its name to Oxurion NV in September 2018. Oxurion NV was founded in 1991 and is headquartered in Leuven, Belgium.
Metrics
BasicAdvanced
Market cap
info
€0.8M
P/E ratio
info
0
EPS
info
€2.23
Dividend Yield
info
0.00%
Beta
info
0.16
Forward P/E ratio
info
0
EBIDTA
info
€0.9M
Ex dividend date
info
-
Price & volume
Market cap
info
€0.8M
Average daily volume
info
0.4M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
€0.00
Dividend yield
info
0.00%
Forward dividend per share
info
€0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
406.89
Price to book
info
6.25
Earnings
EPS
info
€2.23
EPS estimate (current quarter)
info
€0.00
EPS estimate (next quarter)
info
€0.00
EBITDA
info
€0.9M
Revenues (TTM)
info
€0M
Revenues per share (TTM)
info
€0.00
Technicals
Beta
info
0.16
52-week High
info
€0.33
52-week Low
info
€0.01
50-day moving average
info
€0.02
200-day moving average
info
€0.07
Short ratio
info
0
Short %
info
0.00%
Management effectiveness
ROE (TTM)
info
-694.15%
ROA (TTM)
info
11.81%
Profit margin
info
97,950.00%
Gross profit margin
info
€-0M
Operating margin
info
45,050.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
-97.60%
Share stats
Outstanding Shares
info
62.6M
Float
info
4.1M
Insiders %
info
17.11%
Institutions %
info
-
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-
-€0.70
100.00%
Q4 • 13Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
€0M
€3.1M
157,300.00%
Q4 • 24
€-1.2M
0.00%
Q2 • 25
NaN%
-137.73%
0.00%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
€5.7M
€16.8M
294.17%
Q4 • 24
€5M
€17M
340.86%
Q2 • 25
-12.55%
1.33%
15.87%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
€-0.4M
-
€0.8M
€-0.4M
Q4 • 24
€-1.2M
-
€0.6M
€-1.2M
Q2 • 25
165.75%
-
-21.50%
165.75%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Oxurion NV share?
Collapse

Oxurion NV shares are currently traded for undefined per share.

How many shares does Oxurion NV have?
Collapse

Oxurion NV currently has 62.6M shares.

Does Oxurion NV pay dividends?
Collapse

No, Oxurion NV doesn't pay dividends.

What is Oxurion NV 52 week high?
Collapse

Oxurion NV 52 week high is €0.33.

What is Oxurion NV 52 week low?
Collapse

Oxurion NV 52 week low is €0.01.

What is the 200-day moving average of Oxurion NV?
Collapse

Oxurion NV 200-day moving average is €0.07.

Who is Oxurion NV CEO?
Collapse

The CEO of Oxurion NV is Pascal Ghoson.

How many employees Oxurion NV has?
Collapse

Oxurion NV has 11 employees.

What is the market cap of Oxurion NV?
Collapse

The market cap of Oxurion NV is €0.8M.

What is the P/E of Oxurion NV?
Collapse

The current P/E of Oxurion NV is 0.

What is the EPS of Oxurion NV?
Collapse

The EPS of Oxurion NV is €2.23.

What is the PEG Ratio of Oxurion NV?
Collapse

The PEG Ratio of Oxurion NV is null.